Capital Point Ltd.

13D and 13G Filings

13D/G filings
13G on 1 security
CIK
0001634113
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13G · 1 security · passive
Nasus Pharma Ltd. 13G
NSRX · M7071P109
6.4% 8/20/2025
Event 8/14/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.